Silvia Grassilli

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133high to CD133low phenotype and reduces the CD133-related invasiveness

Federica Brugnoli, Silvia Grassilli, Manuela Piazzi et al. · Molecular Cancer · 2013 · 47 citations · Full text

Medicine, Cell Biology, Oncology +17

Vav1 is necessary for <scp>PU</scp>.1 mediated upmodulation of miR‐29b in acute myeloid leukaemia‐derived cells

Federica Vezzali, Silvia Grassilli, Elisabetta Lambertini et al. · Journal of Cellular and Molecular Medicine · 2018 · 40 citations · Full text

Life Sciences, Hematology, Molecular Biology +14

Vav1 and PU.1 are recruited to the CD11b promoter in APL-derived promyelocytes: Role of Vav1 in modulating PU.1-containing complexes during ATRA-induced differentiation

Federica Brugnoli, Elisabetta Lambertini, Nadine Varin‐Blank et al. · Experimental Cell Research · 2009 · 34 citations

Life Sciences, Cell Biology, Molecular Biology +6

High nuclear level of Vav1 is a positive prognostic factor in early invasive breast tumors: a role in modulating genes related to the efficiency of metastatic process

Silvia Grassilli, Federica Brugnoli, Rossano Lattanzio et al. · Oncotarget · 2014 · 31 citations · Full text

Medicine, Oncology, Pathology +14

Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: a promising target for preventing progression of TNBC

Federica Brugnoli, Silvia Grassilli, Paola Lanuti et al. · BMC Cancer · 2017 · 28 citations · Full text

Medicine, Cell Biology, Oncology +17